GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of INBX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Inhibrx Inc stock price down 0.377% on Friday
(Updated on Apr 19, 2024)

Sell candidate since Apr 11, 2024 Loss -2.00% PDF

The Inhibrx Inc stock price fell by -0.377% on the last day (Friday, 19th Apr 2024) from $34.45 to $34.32. During the last trading day the stock fluctuated 1.08% from a day low at $34.22 to a day high of $34.60. The price has fallen in 6 of the last 10 days and is down by -1.86% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -196 thousand shares and in total, 208 thousand shares were bought and sold for approximately $7.14 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -9.29% during the next 3 months and, with a 90% probability hold a price between $26.77 and $33.82 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

INBX Signals & Forecast

There are few to no technical positive signals at the moment. The Inhibrx Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $34.68 and $35.06. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, February 27, 2024, and so far it has fallen -13.25%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Inhibrx Inc stock

Inhibrx Inc finds support from accumulated volume at $33.33 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0.371 between high and low, or 1.08%. For the last week the stock has had daily average volatility of 0.95%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (INBX) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Inhibrx Inc to open at $34.38, and during the day (based on 14 day Average True Range), to move between $33.85 and $34.79, which gives a possible trading interval of +/-$0.465 (+/-1.36%) up or down from last closing price. If Inhibrx Inc takes out the full calculated possible swing range there will be an estimated 2.71% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $35.00 (1.98%) than the support at $33.33 (2.88%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Inhibrx Inc stock A Buy?

Inhibrx Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.771 Sell Candidate Unchanged

Predicted Opening Price for Inhibrx Inc of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$34.38 ( 0.174%) $34.32

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for INBX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 34.75 1.26 %
R2 34.61 0.84 %
R1 34.52 0.587 %
Current price: 34.32
Support S1 34.24 -0.240 %
S2 34.15 -0.495 %
S3 34.01 -0.91 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 36.30 5.77 %
R2 35.64 3.85 %
R1 35.00 1.98 %
Current price 34.32
Support S1 33.33 -2.88%
S2 0 .
S3 0 .

FAQ

What is the symbol for Inhibrx Inc Stock and on which exchange is it traded?
The symbol for Inhibrx Inc is INBX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Inhibrx Inc Stock?
Inhibrx Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Inhibrx Inc Stock?
Inhibrx Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Inhibrx Inc Stock.

What's the current price of Inhibrx Inc Stock?
As of the end of day on the 2024-04-19, the price of an Inhibrx Inc (INBX) share was $34.32.

What is the 52-week high and low for Inhibrx Inc Stock?
The 52-week high for Inhibrx Inc Stock is $39.79 and the 52-week low is $14.31.

What is the market capitalization of Inhibrx Inc Stock?
As of the 2024-04-19, the market capitalization of Inhibrx Inc is 1.627B.

When is the next earnings date for Inhibrx Inc?
The upcoming earnings date for Inhibrx Inc is May 13, 2024.
Click to get the best stock tips daily for free!

About Inhibrx Inc

Inhibrx Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcinoma; INBRX-105, a tetravalent conditional agonist of programmed death-ligand 1 and a conditional agonis... INBX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT